Improve patient activation with behavioral modification techniques.
trustr Abstract Winner of 2020 Gold Ribbon!
Measure Outcomes Instantly
Take advantage of continuous data.
trustr delivers data directly from your patients allowing any degree of monitoring you choose.
With trustr, send conversational surveys and collect pre-processed data.
Motivate Improved Adherence
Increase efficacy and overall health.
trustr motivates good treatments management . You can include your own encouragement and check in on results.
Improve Patient Connectivity
Accelerate response time and safety.
trustr is the simplest and fastest tool to connect with patients outside the doctor’s office with no additional workload required.
Connect with your patients
From clinical trials to post-approval, trustr can motivate towards improved adherence in the period known as “beyond the pill,” leading to a safer and simpler way to collect actionable data on adverse events
trustr can be your "beyond the pill" chatbot to help measuring the clinical and cost effectiveness of pharmacologic drugs, with a continuous flow of data, conversational surveys, reminders and tips.
Activate patients in their wellness journey.
Half the battle of improving patient outcomes is to motivate patients in their wellness journey. trustr is able to engage high risk/hard to reach individuals and motivate them towards healthy change. With no additional device or workload required.
Understanding the occurence, evolution and location of pain throughout the days is critical to make good care decisions. trustr sends your surveys in the form of a conversation, and patients answers are converted into actionable data. In the meantime, trustr engage your patients in their wellness journey and motivate healthy change.
Global 10 Pharmaceutical Company
trustr was engaged by a Global 10 Pharmaceutical Company to launch a North American campaign to better understand the needs of patients with asthma. This data-rich exercise leveraged our understanding of rewards and behavioral economics to drive continued engagement across the 30-60 day windows of sequential studies. At the end of each phase we discovered new knowledge that was immediately useful to the client and immediately useful to patients. We then created a “Pharma Module” for specific enterprise pharmaceutical customers that can enable an organization to launch any campaign, including for rewarding compliance, for rewarding feedback, and for the sharing of intelligent patient reported outcomes (iPROs).